The U.S. announced Thursday that it will make an investment in the new HIV prevention drug called lenacapavir that's been hailed as a " breakthrough " and a " game changer " by the medical community.

The Department of State says the aim is to reach up to 2 million people by 2028 with the antiretroviral medication that has the potential to save hundreds of thousands of lives. Over the coming months, the U.S. will be working with countries with the largest HIV/AIDS epidemics to develop rollout strategies with a focus on preventing mother-to-child transmission.

This announcement has been welcomed by researchers and specialists who focus on HIV/AIDS. This news comes after the Trump administration's foreign cuts have severely impacted clinics and programs in lower resource countries t

See Full Page